158 related articles for article (PubMed ID: 36660627)
1. Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer.
Zhang L; Jiang Y; Jiang P; Chen Z; Cui H; Zhang Y
Ann Transl Med; 2022 Dec; 10(24):1322. PubMed ID: 36660627
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
Wu Y; Jiang P; Chen Z; Li W; Dong B; Zhang Y
BMC Cancer; 2024 May; 24(1):589. PubMed ID: 38745137
[TBL] [Abstract][Full Text] [Related]
3. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
Ao M; Li P; Sun D; Li X; Xu S; Hao Y
J Obstet Gynaecol; 2023 Dec; 43(1):2179915. PubMed ID: 37001548
[TBL] [Abstract][Full Text] [Related]
4. Clinical study of nimotuzumab combined with concurrent radiochemotherapy for treatment of locally advanced cervical cancer.
Chen W; Li T; Wang J; Liang L; Huang D; Yan G; Tian Y; Zhang X; Zhang W
Cancer Manag Res; 2019; 11():8157-8165. PubMed ID: 31564975
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis.
Liu H; Ma X; Sun C; Wu M; Xu Z; Zhou S; Yao N; Liu S; Qin X; Han Z
Front Oncol; 2022; 12():997030. PubMed ID: 36568251
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
Hua L; Wei M; Feng C; Li S; Wen X; Chen S
Cancer Biother Radiopharm; 2024 Jun; ():. PubMed ID: 38828494
[No Abstract] [Full Text] [Related]
7. The Therapeutic Value of Adjuvant Chemotherapy after Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
Wang YN; Zhong ML; Liang MR; Yang JT; Zeng SY
Gynecol Obstet Invest; 2023; 88(5):286-293. PubMed ID: 37497957
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
Li J; Li Y; Wang H; Shen L; Wang Q; Shao S; Shen Y; Xu H; Liu H; Cai R; Feng W
BMC Cancer; 2023 Jan; 23(1):51. PubMed ID: 36641433
[TBL] [Abstract][Full Text] [Related]
9. Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
Li F; Mei F; Yin S; Du Y; Hu L; Hong W; Li J
J Gynecol Oncol; 2024 Jan; 35(1):e10. PubMed ID: 37857565
[TBL] [Abstract][Full Text] [Related]
10. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma.
Wang L; Zhuang H; Xu X; Zhou J; Jiao Y
Front Oncol; 2023; 13():1129649. PubMed ID: 36814816
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
Kou L; Zhang T; Yang X; Peng S; Wang Y; Yuan M; Li M
Future Oncol; 2022 May; 18(16):1917-1915. PubMed ID: 35193379
[No Abstract] [Full Text] [Related]
13. Correlations between alterations of T-helper 17 cells and treatment efficacy after concurrent radiochemotherapy in locally advanced cervical cancer (stage IIB-IIIB): a 3-year prospective study.
Liu Y; Guo QF; Chen JL; Li XR; Hou F; Liu XY; Zhang WJ; Zhang Y; Gao FF; Zhang YZ; Cui BX; Liu NF
Chin Med J (Engl); 2021 Apr; 134(8):954-962. PubMed ID: 33840740
[TBL] [Abstract][Full Text] [Related]
14. Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Chen Z; Long X; Pang Q; Peng L; Li X; Gu J; Deng S; Xing L
Oncol Res; 2022 Jan; 28(9):929-944. PubMed ID: 34544526
[TBL] [Abstract][Full Text] [Related]
15. Research on the efficacy of cisplatin and nimotuzumab combined with concurrent chemoradiotherapy on locally advanced cervical cancer.
Cao Y; Deng L; Lian S; Jiang Y
J BUON; 2019; 24(5):2013-2019. PubMed ID: 31786869
[TBL] [Abstract][Full Text] [Related]
16. Operation for locally advanced cervical cancer after concurrent chemoradiotherapy.
Ge J; Sun J; Li J; Zhang Q; Lv X; Chen B
Int J Clin Oncol; 2020 May; 25(5):948-954. PubMed ID: 32236755
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant and Adjuvant Treatments Compared to Concurrent Chemoradiotherapy for Patients With Locally Advanced Cervical Cancer: A Bayesian Network Meta-Analysis.
Qiao Y; Li H; Peng B
Front Oncol; 2022; 12():745522. PubMed ID: 35372073
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma.
Lin M; You R; Liu YP; Zhang YN; Zhang HJ; Zou X; Yang Q; Li CF; Hua YJ; Yu T; Cao JY; Li JB; Mo HY; Guo L; Lin AH; Sun Y; Qian CN; Ma J; Mai HQ; Chen MY
Oral Oncol; 2018 May; 80():1-8. PubMed ID: 29706183
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial.
Qiu B; Wang D; Li Q; Wu Y; Guo S; Jiang X; Fang J; Guo J; Liu F; Chu C; Wang B; Chen L; Zhang J; Liu Y; Hu Y; Liu H
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):917-925. PubMed ID: 34229051
[TBL] [Abstract][Full Text] [Related]
20. Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients.
Lee SY; Lee DH; Cho DH
Medicine (Baltimore); 2023 Jan; 102(3):e32727. PubMed ID: 36701697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]